Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-13 Pomerantz Roger Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-09-07 Pomerantz Roger President and CEO Sale −1,810 $9.00 $16K 213,976
2018-09-06 Pomerantz Roger President and CEO Sale −3,013 $9.04 $27K 215,786
2018-09-05 Pomerantz Roger President and CEO Sale −9,505 $9.12 $87K 218,799
2018-07-11 Pomerantz Roger President and CEO Exercise or conversion +1,010 $0.71 $717 229,314
2018-07-11 Pomerantz Roger President and CEO Sale −1,010 $9.01 $9K 228,304
2018-07-11 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −1,010 797,536
2018-07-10 Pomerantz Roger President and CEO Exercise or conversion +5,989 $0.71 $4K 234,293
2018-07-10 Pomerantz Roger President and CEO Sale −5,989 $9.05 $54K 228,304
2018-07-10 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −5,989 798,546
2018-07-09 Pomerantz Roger President and CEO Exercise or conversion +10,981 $0.71 $8K 239,285
2018-07-09 Pomerantz Roger President and CEO Sale −10,981 $9.14 $100K 228,304
2018-07-09 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −10,981 804,535
2018-07-06 Pomerantz Roger President and CEO Exercise or conversion +15,366 $0.71 $11K 243,670
2018-07-06 Pomerantz Roger President and CEO Sale −15,366 $9.14 $141K 228,304
2018-07-06 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −15,366 815,516
2018-06-29 Pomerantz Roger President and CEO Exercise or conversion +4,496 $0.71 $3K 232,800
2018-06-29 Pomerantz Roger President and CEO Sale −4,496 $9.10 $41K 228,304
2018-06-29 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −4,496 830,882
2018-06-28 Pomerantz Roger President and CEO Exercise or conversion +21,560 $0.71 $15K 249,864

Page 1 of 4 · 62 trades